Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilias Ettayebi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Methods in Enzymology|November 16, 2019
Methods to detect endogenous dsRNA induction and recognitionIlias Ettayebi, Helen Loo Yau, Daniel D De Carvalho
Trends in Cell Biology|August 30, 2018
The Cancer Epigenome: Exploiting Its Vulnerabilities for ImmunotherapyHelen Loo Yau, Ilias Ettayebi, Daniel D De Carvalho
Nature|October 22, 2020
Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependencyParinaz Mehdipour, Sajid A Marhon, Ilias Ettayebi, et al.
Nature|March 3, 2021
Publisher Correction: Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependencyParinaz Mehdipour, Sajid A Marhon, Ilias Ettayebi, et al.
British Journal of Haematology|September 19, 2023
Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemiaFabíola Attié de Castro, Parinaz Mehdipour, Ankur Chakravarthy, et al.
Nature Communications|October 30, 2024
Inhibiting EZH2 targets atypical teratoid rhabdoid tumor by triggering viral mimicry via both RNA and DNA sensing pathwaysShengrui Feng, Sajid A Marhon, Dustin J Sokolowski, et al.
Cancer Discovery|June 18, 2020
Epigenetic Switch-Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast CancerGeneviève Deblois, Seyed Ali Madani Tonekaboni, Giacomo Grillo, et al.
Journal for Immunotherapy of Cancer|August 6, 2020
An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumorsKirsty Taylor, Helen Loo Yau, Ankur Chakravarthy, et al.
Molecular Cell|February 20, 2021
DNA hypomethylating agents increase activation and cytolytic activity of CD8<sup>+</sup> T cellsHelen Loo Yau, Emma Bell, Ilias Ettayebi, et al.
Nature|November 16, 2018
Sensitive tumour detection and classification using plasma cell-free DNA methylomesShu Yi Shen, Rajat Singhania, Gordon Fehringer, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Methods in Enzymology|November 16, 2019
Methods to detect endogenous dsRNA induction and recognitionIlias Ettayebi, Helen Loo Yau, Daniel D De Carvalho
Trends in Cell Biology|August 30, 2018
The Cancer Epigenome: Exploiting Its Vulnerabilities for ImmunotherapyHelen Loo Yau, Ilias Ettayebi, Daniel D De Carvalho
Nature|October 22, 2020
Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependencyParinaz Mehdipour, Sajid A Marhon, Ilias Ettayebi, et al.
Nature|March 3, 2021
Publisher Correction: Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependencyParinaz Mehdipour, Sajid A Marhon, Ilias Ettayebi, et al.
British Journal of Haematology|September 19, 2023
Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemiaFabíola Attié de Castro, Parinaz Mehdipour, Ankur Chakravarthy, et al.
Nature Communications|October 30, 2024
Inhibiting EZH2 targets atypical teratoid rhabdoid tumor by triggering viral mimicry via both RNA and DNA sensing pathwaysShengrui Feng, Sajid A Marhon, Dustin J Sokolowski, et al.
Cancer Discovery|June 18, 2020
Epigenetic Switch-Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast CancerGeneviève Deblois, Seyed Ali Madani Tonekaboni, Giacomo Grillo, et al.
Journal for Immunotherapy of Cancer|August 6, 2020
An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumorsKirsty Taylor, Helen Loo Yau, Ankur Chakravarthy, et al.
Molecular Cell|February 20, 2021
DNA hypomethylating agents increase activation and cytolytic activity of CD8<sup>+</sup> T cellsHelen Loo Yau, Emma Bell, Ilias Ettayebi, et al.
Nature|November 16, 2018
Sensitive tumour detection and classification using plasma cell-free DNA methylomesShu Yi Shen, Rajat Singhania, Gordon Fehringer, et al.
Pageof 2